{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05231",
      "entity_text" : "interleukin-6",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00173",
      "entity_text" : "major histocompatibility complex class I H-2L d  gene",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "We have previously reported that transgenic mice with human interleukin-6 (hIL6) driven by the major histocompatibility complex class I H-2L d gene promoter develop symptoms similar to Castleman 's disease in human XREF_BIBR XREF_BIBR XREF_BIBR such as lymphadenopathy, massive immunoglobulin G1 plasmacytosis, splenomegaly, mesangial proliferative glomerulonephritis, thrombocytopenia, leukocytosis, anemia and muscle atrophy XREF_BIBR XREF_BIBR.",
  "reading_complete" : "2020-08-04T09:02:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:01:17Z",
  "trigger" : "driven",
  "evidence" : [ "interleukin-6 (hIL6) driven by the major histocompatibility complex class I H-2L d  gene" ],
  "pmc_id" : "3561642",
  "score" : 0
}